JP2016519659A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519659A5 JP2016519659A5 JP2016502225A JP2016502225A JP2016519659A5 JP 2016519659 A5 JP2016519659 A5 JP 2016519659A5 JP 2016502225 A JP2016502225 A JP 2016502225A JP 2016502225 A JP2016502225 A JP 2016502225A JP 2016519659 A5 JP2016519659 A5 JP 2016519659A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- use according
- independently
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361794094P | 2013-03-15 | 2013-03-15 | |
| US61/794,094 | 2013-03-15 | ||
| PCT/US2014/026722 WO2014151953A1 (en) | 2013-03-15 | 2014-03-13 | Compounds and methods for inducing chondrogenesis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519659A JP2016519659A (ja) | 2016-07-07 |
| JP2016519659A5 true JP2016519659A5 (enExample) | 2017-04-13 |
| JP6579623B2 JP6579623B2 (ja) | 2019-09-25 |
Family
ID=51528123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502225A Active JP6579623B2 (ja) | 2013-03-15 | 2014-03-13 | 軟骨形成を誘導するための化合物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10500210B2 (enExample) |
| EP (1) | EP2968330B1 (enExample) |
| JP (1) | JP6579623B2 (enExample) |
| KR (1) | KR102283996B1 (enExample) |
| CN (3) | CN107007587A (enExample) |
| AU (1) | AU2014236719B2 (enExample) |
| CA (1) | CA2904160C (enExample) |
| ES (1) | ES2900815T3 (enExample) |
| HK (1) | HK1224172A1 (enExample) |
| WO (1) | WO2014151953A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012129562A2 (en) * | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| AU2014236719B2 (en) | 2013-03-15 | 2018-06-21 | The California Institute For Biomedical Research | Compounds and methods for inducing chondrogenesis |
| CN105294533A (zh) * | 2015-12-02 | 2016-02-03 | 宋彤云 | 一种治疗骨病的药物组合物 |
| CN109963579A (zh) * | 2016-11-14 | 2019-07-02 | 诺华股份有限公司 | 用于治疗软骨损伤和关节炎的方法和组合物 |
| EP3615021A4 (en) * | 2017-04-24 | 2020-12-30 | The Scripps Research Institute | CHONDROGENESIS INDUCTION METHODS |
| UY37759A (es) | 2017-06-09 | 2019-01-31 | Novartis Ag | Compuestos y composiciones para inducir condrogénesis |
| CN107056677A (zh) * | 2017-06-19 | 2017-08-18 | 常州大学 | 一种3‑烷基2,3‑二氢异吲哚啉酮衍生物的合成方法 |
| SG11202008536QA (en) * | 2018-03-29 | 2020-10-29 | Elex Biotech Inc | Compounds for treatment of cardiac arrhythmias and heart failure |
| CN110937987B (zh) * | 2018-09-25 | 2022-09-06 | 深圳市灵兰生物医药科技有限公司 | 一种化合物的合成路线及在抗糖尿病药物制备领域的应用 |
| AU2019362747A1 (en) * | 2018-10-15 | 2021-06-03 | Gero Pte. Ltd. | PFKFB3 inhibitors and their uses |
| CN114105902B (zh) * | 2018-12-28 | 2023-11-03 | 中山大学 | 噻唑苯甲酰胺衍生物及其在制备抗骨质疏松药物中的应用 |
| CN112004798A (zh) * | 2019-01-07 | 2020-11-27 | 江苏凯迪恩医药科技有限公司 | 一种苯甲酰胺类化合物、中间体、制备方法及应用 |
| EP3946301A4 (en) * | 2019-04-02 | 2023-08-09 | The University of Chicago | REMODILINS FOR RESPIRATORY TRACT REMODELING AND ORGAN FIBROSIS |
| US20230310412A1 (en) * | 2020-08-05 | 2023-10-05 | Lg Chem, Ltd. | Use of caspase inhibitor for alleviating or treating osteoarthritis |
| CN114763347B (zh) * | 2021-01-15 | 2024-06-21 | 华东师范大学 | 一类用于诱导间充质干细胞向软骨分化的化合物及其应用 |
| CN114763346B (zh) * | 2021-01-15 | 2025-06-10 | 华东师范大学 | 一类用于诱导软骨形成的化合物及其应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1016623A (en) | 1911-09-06 | 1912-02-06 | Harry Haller Jr | Photographic-printing device. |
| CH489993A (de) | 1967-12-19 | 1970-05-15 | Ciba Geigy | Das Pflanzenwachstum regulierendes und phytocides Mittel |
| FR2059977A1 (enExample) | 1969-08-14 | 1971-06-11 | Socibre | |
| JPH0320253A (ja) * | 1988-06-13 | 1991-01-29 | Ono Pharmaceut Co Ltd | ピバル酸 ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤 |
| US5017610A (en) | 1988-06-13 | 1991-05-21 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-substituted phenyl ester of pivalic acid |
| JPH0959236A (ja) * | 1995-08-23 | 1997-03-04 | Dai Ichi Seiyaku Co Ltd | ベンズアミド化合物 |
| US5729014A (en) | 1996-07-11 | 1998-03-17 | Varian Associates, Inc. | Method for injection of externally produced ions into a quadrupole ion trap |
| JP2002508754A (ja) | 1997-05-22 | 2002-03-19 | ジー ディ サール アンド カンパニ | ｐ３８キナーゼ阻害剤としての置換基を有するピラゾール類 |
| US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
| US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6632961B1 (en) | 1998-05-22 | 2003-10-14 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| US6706712B2 (en) * | 2000-12-20 | 2004-03-16 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
| JP2005194191A (ja) * | 2001-12-28 | 2005-07-21 | Ajinomoto Co Inc | 抗肥満薬、脂肪肝治療薬 |
| WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US7288538B2 (en) * | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| ES2281801T3 (es) | 2003-05-12 | 2007-10-01 | Pfizer Products Inc. | Inhibidores benzamida del receptor p2x7. |
| WO2005013947A2 (en) | 2003-07-29 | 2005-02-17 | Universitätsklinikum Münster | Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
| US7863317B2 (en) * | 2003-08-21 | 2011-01-04 | Bristol-Myers Squibb Company | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7163937B2 (en) * | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
| CN101094829B (zh) | 2004-12-07 | 2012-02-08 | 富山化学工业株式会社 | 新的氨茴酸衍生物或其盐 |
| KR100787131B1 (ko) | 2006-07-04 | 2007-12-21 | 한국생명공학연구원 | Ｈｉｆ―１ 활성을 저해하는 화합물, 이의 제조방법 및이를 유효성분으로 함유하는 약학적 조성물 |
| EP2172198B1 (en) * | 2007-07-20 | 2014-04-16 | Chugai Seiyaku Kabushiki Kaisha | p27 PROTEIN INDUCER |
| MX2010003071A (es) * | 2007-10-05 | 2010-04-01 | Sanofi Aventis Deutschland | Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor. |
| US8143269B2 (en) * | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| PT2453921E (pt) | 2009-07-14 | 2015-09-25 | Novartis Ag | Diferenciação de células estaminais mesenquimais |
| CN103038232B (zh) | 2010-05-26 | 2016-01-20 | 阿德弗里奥药品有限责任公司 | 单独的和与PDE5抑制剂相组合的sGC刺激剂、sGC活化剂用于治疗系统性硬化症(SSc)的用途 |
| WO2012129562A2 (en) | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| AU2014236719B2 (en) | 2013-03-15 | 2018-06-21 | The California Institute For Biomedical Research | Compounds and methods for inducing chondrogenesis |
| MY186570A (en) | 2014-05-13 | 2021-07-27 | Novartis Ag | Compounds and compositions for inducing chondrogenesis |
-
2014
- 2014-03-13 AU AU2014236719A patent/AU2014236719B2/en active Active
- 2014-03-13 WO PCT/US2014/026722 patent/WO2014151953A1/en not_active Ceased
- 2014-03-13 HK HK16107019.4A patent/HK1224172A1/zh unknown
- 2014-03-13 US US14/774,673 patent/US10500210B2/en active Active
- 2014-03-13 EP EP14770543.8A patent/EP2968330B1/en active Active
- 2014-03-13 US US14/210,198 patent/US9452170B2/en active Active
- 2014-03-13 CA CA2904160A patent/CA2904160C/en active Active
- 2014-03-13 CN CN201710295821.6A patent/CN107007587A/zh active Pending
- 2014-03-13 ES ES14770543T patent/ES2900815T3/es active Active
- 2014-03-13 JP JP2016502225A patent/JP6579623B2/ja active Active
- 2014-03-13 KR KR1020157026707A patent/KR102283996B1/ko active Active
- 2014-03-13 CN CN201480028421.3A patent/CN105228626A/zh active Pending
- 2014-03-13 CN CN202211717279.6A patent/CN116059196A/zh active Pending
-
2019
- 2019-11-15 US US16/685,555 patent/US11045476B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275348B2 (en) | Carbamoyl cyclohexyl acids linked via n triazole as lpa antagonists | |
| MX2020006599A (es) | Composiciones y metodos para el tratamiento de trastornos en el sistema nervioso central. | |
| JP2015537020A5 (enExample) | ||
| MY194087A (en) | Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament | |
| MX2018004364A (es) | Acidos pirazolo [3,4-b] piridin-6-carboxilicos sustituidos y su uso. | |
| ECSP066730A (es) | Compuestos y procedimientos para uso | |
| DOP2013000191A (es) | Derivados de heteroarilo como modulares de nachr alfa 7 | |
| WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
| IN2014CN03803A (enExample) | ||
| BR112014029016A2 (pt) | derivados de ácido 7-oxo-tiazolopiridina carbônico e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| BR112014008412A2 (pt) | derivados de pirimidin-4-ona e sua utilização no tratamento, na melhora ou na prevenção de uma doença viral | |
| NZ721645A (en) | Compounds for use as gpr120 agonists | |
| CL2016000816A1 (es) | Forma de dosificación que comprende al compuesto (s)-3-(4-((4-morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona, una cantidad de 90 hasta 99,9 por ciento en peso del peso total de una mezcla de almidón y lactosa como portador o excipiente, y acido esteárico como lubricante; su uso en el tratamiento de cáncer y enfermedades autoinmunes, entre otras. | |
| MX2016011105A (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos. | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| PH12013501117A1 (en) | Novel compound and medical use thereof | |
| JP2015502371A5 (enExample) | ||
| UY32435A (es) | 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona útil en el tratamiento de enfermedades pulmonares | |
| NI200900161A (es) | Sales de adición de ácido, hidratos y polimorfos de la etil - amida del ácido 5 - (2,4 -dihidroxi -5- isopropil - fenil) -4- (4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden estas formas. | |
| UY28896A1 (es) | Formulaciones en polvo para la inhalación , las cuales contienen beta-agonistas enantioméricamente puros | |
| MX2020002432A (es) | Composicion farmaceutica. | |
| WO2014001215A3 (en) | 3-o-heteroaryl-ingenol | |
| MX2022011242A (es) | Inmunomodulación de o-het/aril azálidos. | |
| CL2021000627A1 (es) | Composiciones farmacéuticas adecuadas para liberación articular y su uso en el tratamiento del dolor articular | |
| AR102019A1 (es) | (r)-3-((3s,4s)-3-fluoro-4-(4-hidroxifenil)piperidin-1-il)-1-(4-metilbencil)pirrolidin-2-ona y sus profármacos para el tratamiento de trastornos psiquiátricos |